Cardiovascular Diseases

Early Life Vascular Risk Linked to Brain Pathology Later

A prospective longitudinal cohort study in Britain revealed that early adulthood vascular risk is strongly associated with smaller whole-brain volume (WBV) and greater white matter–hyperintensity volume (WMHV) at age 69 to 71 years. The study assessed 502 participants in a birth cohort in 1946. Framingham Heart study–cardiovascular risk scores (FHS-CVS) were derived at ages 36, 53, and 69 years, respectively. 463 participants (236 male) with at least 1 available imaging measure (mean age at imaging, 70.7 years; 83 β-amyloid positive) who fulfilled eligibility criteria were included. Among them, FHS-CVS increased with age (median 2.7%, 10.9%, and 24.3% for 36, 53, and 69 years, respectively). At all points, these scores were associated with smaller WBV (β coefficient per 1% increase, −3.6, −0.8, and −0.6 for 36, 53, and 69 years, respectively) and higher WMHV (exponentiated coefficient: 1.09, 1.02, and 1.01 for 36, 53, and 69 years, respectively), with largest effect sizes at age 36 years. At no point were FHS-CVS results associated with β-amyloid status. The findings are consistent with increasing evidence that vascular risk factors impact on an individual’s risk for developing dementia and suggest that reducing vascular risk with appropriate interventions should be considered from early adulthood for late-life brain health. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Mindfulness-Based Stress Reduction on Par with Escitalopram for Anxiety Disorders

Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…

4 days ago

Key Messages of 2024 ESC Guidelines for High BP

The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…

1 month ago

CRP, LDL Cholesterol, and Lipoprotein(a) Levels Predictive of CVD

A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…

1 month ago

No Benefit to Stop Beta-Blockers After MI

A French multicenter, open label, randomized, noninferiority trial suggested that interruption of long-term beta-blocker treatment…

2 months ago

Plant vs Animal Fat on Mortality

A US prospective cohort study demonstrated that replacement of animal fat with an equivalent amount…

2 months ago

UK T2D Remission Program Findings

An ongoing UK national prospective program shows remission of type 2 diabetes (T2D) outside of…

2 months ago

This website uses cookies.